-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_research-protocol.pdf
April 01, 2013 - Tumor (T) stages
Stage Description
T1 The tumor cannot be felt or seen using imaging techniques
T1a … Lymph node (N) stages
Stage Description
NX Nearby lymph nodes were not assessed
N0 The cancer has … publications reporting subgroups, other outcomes, longer
followup) will be identified by examining author … meta-analyses
are possible, meta-regression models will be used to analyze possible interactions with the year … OR (year
ADJ old).ti,ab.)
10 Limit Limit 9 to English and humans and yr=“2007-Current”
11 Remove
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/off-label-use-research-priorities_research.pdf
May 01, 2009 - ........................................................................................... 18
Author … P res c ribing Data
For its large size (approximately 200,000 contact records per year), national scope … to year. … Report Number 12
18
Appendix
The purpose of this appendix is to augment the detailed study description … of the TEP
Further Description of Methods and Coding
Further Description of Technical Expert Panel
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
April 01, 2021 - Strategies for addressing insufficient evidence in evidence synthesis programs*
Strategy Description … Example Example Description
Reconsider eligible study
designs
In designing the original
protocol … Example Example Description
Summarize evidence on
contextual factors (factors
other than benefits … Example Example Description
Incorporate health system
data into a review
Local health system data … Heart. 2010 Aug;96(16):1333;
author reply doi:
https://dx.doi.org/10.1136/hrt.2010.200758.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief2-opioid-withdrawal.pdf
April 01, 2021 - to the systematic reviews found that
among patients prescribed long-term opioid therapy in the last year … Studies of treatments to support opioid tapering in patients with chronic pain
Strategy Description … Patient-centered prescription opioid tapering
in community outpatients with chronic pain:
2- to 3-year … This report is made available to the public under the terms of a licensing agreement between the
author … See Appendix B for detailed description of the criteria.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief2-opioid-withdrawal.pdf
April 01, 2021 - to the systematic reviews found that
among patients prescribed long-term opioid therapy in the last year … Studies of treatments to support opioid tapering in patients with chronic pain
Strategy Description … Patient-centered prescription opioid tapering
in community outpatients with chronic pain:
2- to 3-year … This report is made available to the public under the terms of a licensing agreement between the
author … See Appendix B for detailed description of the criteria.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
April 25, 2022 - Postpartum Care for Women Up to One Year After Pregnancy
Evidence-based Practice Center … Systematic Review Protocol
Project Title: Postpartum Care for Women Up to One Year After Pregnancy … 11.8).2 Approximately half (52%) of the deaths occurred in the postpartum period (defined
as up to 1 year … after giving birth).2, 3 Additionally, up to 70,000 individuals per year in the U.S. experience
severe … For KQ 1b: 3 months to 1
year after giving birth (except interpregnancy interval, unintended
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
September 01, 2011 - the differentiation into Tiers 1-3 and MMD alone or mixed
groups, I struggled to find a compelling description … Earlier this year, Janicak and
colleagues published the results of a 6-month naturalistic follow-up … Peer Reviewer
#8
General Nemeroff [et al., PNAS, 2003—and Michael Thase was a co-author]
studied … "Two-year outcome of vagus
nerve stimulation in treatment-resistant depression." … "Two-year outcome of vagus
nerve stimulation (VNS) for treatment of major depressive episodes."
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-disposition-comments.pdf
January 01, 2020 - The table does not include any
description of “time frame” as required by the
PICOTS framework. … standard list to assess all potentially eligible
studies, and do not go back in time to match the year … There is room in the first column if this could be
explanded to Author, Year, Country, ROB. … TEP Reviewer 1 Discussion/
Conclusion
Other comments
Pg 113 Ln 16-18
The description of studies … The way it is written, the text sometimes
conveys it was the author who did not analyze
by subgroup
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline-disposition-170707pdf.pdf
March 24, 2017 - It includes a reasonable background
literature description, it provides definitions for
relevant terminology … Did you follow this
approach and if yes, revise this description to improve
clarity. … We have revised some elements of the
description of the ACTIVE trial. … We have revised our description of the booster
assignment but it does not alter the bias
conclusion … They do a good job with their
description of how bias was rated.
-
effectivehealthcare.ahrq.gov/sites/default/files/cognitive-decline-disposition-170707pdf.pdf
March 24, 2017 - It includes a reasonable background
literature description, it provides definitions for
relevant terminology … Did you follow this
approach and if yes, revise this description to improve
clarity. … We have revised some elements of the
description of the ACTIVE trial. … We have revised our description of the booster
assignment but it does not alter the bias
conclusion … They do a good job with their
description of how bias was rated.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_disposition-comments.pdf
March 01, 2012 - pre-existing
conditions documented, are all identical to
those reported in another study by the same
author … We reworded the sample description to clarify
that all subjects had recurrent CDI. … We reworded the sample description to clarify
that all subjects had recurrent CDI
Peer Reviewer
#4 … PCP office in a flowchart method – IF patient presents with
weight loss AND had surgery in the past year … Description of studies evaluating risk
factors for Clostridium difficile associated diarrhea
(CDAD)
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-search_methods.pdf
July 01, 2012 - MEDLINE
EMCare http://www.elsevier.com/wps/find/bibliographicdataba
sedescription.cws_home/708272/description … #
description
Nursing and allied health
Global Health http://www.cabi.org/datapage.asp? … Stroke,
2008. 39(8):e139; author reply e140.
[Comment on Stroke 2008;39(6):1911-9.]
23. … Conflicts of interest: The author has no affiliations or financial involvements that conflict with
the … Corresponding author: Rose Relevo, M.L.I.S., M.S.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/telehealth_disposition-comments.pdf
June 30, 2016 - section on how we incorporated quality
criteria for the systematic reviews into our inclusion
and description … Tables can
be copied and if they have a
fuller description of what each
contains via the title, the … TeleMental Health
The number of veterans
receiving care through telehealth
is climbing by 22% each year … Riley, PhD,
corresponding author
Pamela Keberlein, RN, MSN,
Gigi Sorenson, RN, MSN,
Sailor Mohler … We revised the description of inclusion criteria to
clarify that we did not restrict our inclusion to
-
effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
January 01, 2010 - These spreadsheets will allow each author to count
key data points, such as study location, study type … evidence table will
vary by key question, but the tables will contain some common elements, such as author … , year of
publication, study location (e.g., country, city, state) and time period, population description … Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002
Principal Investigators … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied
by a description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
December 09, 2009 - These spreadsheets will allow each author to count
key data points, such as study location, study type … evidence table will
vary by key question, but the tables will contain some common elements, such as author … , year of
publication, study location (e.g., country, city, state) and time period, population description … Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002
Principal Investigators … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied
by a description
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_disposition-comments.pdf
October 01, 2010 - evidence to show that
adverse events associated with RFA are relatively
uncommon….based on the study description … Nonrandomized studies of AF ablation that measured QoL
outcomes were reviewed earlier this year.(1) … • This study evaluated 105 patients followed for one year. … RFA was superior
to medical treatments at maintaining sinus rhythm in patients with
PAF over one year
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_disposition-comments.pdf
August 12, 2016 - We have added a
short description of FFQ and
their deficiencies regarding
n-3 FA to the introduction … Perhaps a
brief description of the methodology to quantitate omega-3 levels for the
included studies … Thank you
Peer Reviewer #2 Introduction The brief description of the metabolic pathway of conversion … Peer Reviewer #2 Introduction The description of biomarkers used to assess n3 FA levels is appropriate … The sample size was too
small (N<30) in each arm at
1 year followup.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
May 16, 2013 - Cycle 1 (1st assessment)
In total, 4 CER-specific (e.g., lead author, clinical content experts, and … Based on the study description, we surmised that
most of the adverse events either took place in a … . 319 (32%), p=0.005
Source: www.effectivehealthcare.ahrq.gov
Published online: May 16, 2013
Author … 14/61 (23%), p=0.001
Source: www.effectivehealthcare.ahrq.gov
Published online: May 16, 2013
Author … PV NA Complications
Source: www.effectivehealthcare.ahrq.gov
Published online: May 16, 2013
Author
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/predictors-trauma-care_research-protocol.pdf
May 31, 2017 - <90 mmHg
and respiratory rate less <10 or >29 breaths per minute (>20 in infants aged less than 1
year … studies
used to support the trauma triage guidelines has increased 24-fold from approximately
two per year … in the 2006 guidelines to about 48 per year in the 2011 guideline.10 Other
developments, including … Management
For studies that meet inclusion criteria, the following data will be abstracted: study
design, year … risk of bias studies include clear descriptions of the
population, setting, and measures; sufficient description
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol-amendment.pdf
March 22, 2023 - considered normal for their age (e.g., a study on how to manage a toddler’s temper tantrum or an 8-
year-old … Criteria for grading the risk of bias of individual studies
Rating Description and Criteria
Low • Least … Description of the strength of evidence grades
Strength of Evidence Description
High We are very confident … stable or that the estimate of effect is close to the true effect.
11
Strength of Evidence Description